MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.58 (327.00% upside)

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015MLV & Co.Initiated CoverageBuy$1.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014LaidlawInitiated CoverageBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Brinson PatrickInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2014Roth CapitalInitiated CoverageBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)